A detailed history of Concentric Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Concentric Wealth Management, LLC holds 54,695 shares of BMY stock, worth $3.15 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
54,695
Previous 51,090 7.06%
Holding current value
$3.15 Million
Previous $2.12 Million 33.43%
% of portfolio
0.6%
Previous 0.56%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $142,974 - $186,558
3,605 Added 7.06%
54,695 $2.83 Million
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $126,103 - $166,017
3,133 Added 6.53%
51,090 $2.12 Million
Q1 2024

May 08, 2024

BUY
$47.98 - $54.4 $203,675 - $230,928
4,245 Added 9.71%
47,957 $2.6 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $345,129 - $411,834
7,119 Added 19.45%
43,712 $2.24 Million
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $44,575 - $49,842
770 Added 2.15%
36,593 $2.12 Million
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $78,809 - $87,505
1,237 Added 3.58%
35,823 $2.29 Million
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $11,762 - $13,340
179 Added 0.52%
34,586 $2.4 Million
Q4 2022

Feb 10, 2023

SELL
$68.48 - $81.09 $17,256 - $20,434
-252 Reduced 0.73%
34,407 $2.48 Million
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $11 - $6,531
85 Added 0.25%
34,659 $2.46 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $23,601 - $25,993
325 Added 0.95%
34,574 $2.66 Million
Q1 2022

Apr 14, 2022

BUY
$61.48 - $73.72 $41,806 - $50,129
680 Added 2.03%
34,249 $2.5 Million
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $171,079 - $199,438
3,190 Added 10.5%
33,569 $2.09 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $133,605 - $156,501
2,258 Added 8.03%
30,379 $1.8 Million
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $57,204 - $62,296
924 Added 3.4%
28,121 $1.88 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $261,689 - $294,323
4,410 Added 19.35%
27,197 $1.72 Million
Q4 2020

Feb 10, 2021

BUY
$57.74 - $65.43 $155,320 - $176,006
2,690 Added 13.39%
22,787 $1.41 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $1,435 - $1,591
25 Added 0.12%
20,097 $1.21 Million
Q2 2020

Aug 11, 2020

SELL
$54.82 - $64.09 $22,750 - $26,597
-415 Reduced 2.03%
20,072 $1.18 Million
Q1 2020

May 07, 2020

BUY
$46.4 - $67.43 $90,712 - $131,825
1,955 Added 10.55%
20,487 $1.14 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $580,284 - $756,928
11,792 Added 174.96%
18,532 $1.19 Million
Q3 2019

Nov 06, 2019

BUY
$42.77 - $50.71 $5,987 - $7,099
140 Added 2.12%
6,740 $342,000
Q2 2019

Aug 05, 2019

BUY
$44.62 - $49.34 $93,925 - $103,860
2,105 Added 46.83%
6,600 $299,000
Q1 2019

May 08, 2019

BUY
$45.12 - $53.8 $202,814 - $241,831
4,495 New
4,495 $214,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Concentric Wealth Management, LLC Portfolio

Follow Concentric Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concentric Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concentric Wealth Management, LLC with notifications on news.